288 related articles for article (PubMed ID: 33346683)
1. Colchicine Inhibits Neutrophil Extracellular Trap Formation in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention.
Vaidya K; Tucker B; Kurup R; Khandkar C; Pandzic E; Barraclough J; Machet J; Misra A; Kavurma M; Martinez G; Rye KA; Cochran BJ; Patel S
J Am Heart Assoc; 2021 Jan; 10(1):e018993. PubMed ID: 33346683
[TBL] [Abstract][Full Text] [Related]
2. Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention: COLCHICINE-PCI Randomized Trial.
Shah B; Pillinger M; Zhong H; Cronstein B; Xia Y; Lorin JD; Smilowitz NR; Feit F; Ratnapala N; Keller NM; Katz SD
Circ Cardiovasc Interv; 2020 Apr; 13(4):e008717. PubMed ID: 32295417
[TBL] [Abstract][Full Text] [Related]
3. Colchicine to Prevent Periprocedural Myocardial Injury in Percutaneous Coronary Intervention: The COPE-PCI Pilot Trial.
Cole J; Htun N; Lew R; Freilich M; Quinn S; Layland J
Circ Cardiovasc Interv; 2021 May; 14(5):e009992. PubMed ID: 34003667
[TBL] [Abstract][Full Text] [Related]
4. ACTH- and cortisol-associated neutrophil modulation in coronary artery disease patients undergoing stent implantation.
Keresztes M; Horváth T; Ocsovszki I; Földesi I; Serfőző G; Boda K; Ungi I
PLoS One; 2013; 8(8):e71902. PubMed ID: 23967262
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial.
Abtan J; Steg PG; Stone GW; Mahaffey KW; Gibson CM; Hamm CW; Price MJ; Abnousi F; Prats J; Deliargyris EN; White HD; Harrington RA; Bhatt DL;
JACC Cardiovasc Interv; 2016 Sep; 9(18):1905-13. PubMed ID: 27659566
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil-derived microparticles are released into the coronary circulation following percutaneous coronary intervention in acute coronary syndrome patients.
Martínez GJ; Barraclough JY; Nakhla S; Kienzle V; Robertson S; Mallat Z; Celermajer DS; Patel S
Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 27913753
[TBL] [Abstract][Full Text] [Related]
7. COlchicine to Prevent PeriprocEdural Myocardial Injury in Percutaneous Coronary Intervention (COPE-PCI): A Descriptive Cytokine Pilot Sub-Study.
Cole J; Htun N; Lew R; Freilich M; Quinn S; Layland J
Cardiovasc Revasc Med; 2022 Jun; 39():84-89. PubMed ID: 34686461
[TBL] [Abstract][Full Text] [Related]
8. Protective Effects of Salvianolate on Myocardial Injury or Myocardial Infarction after Elective Percutaneous Coronary Intervention in NSTE-ACS Patients: A Randomized Placebo-Controlled Trial.
Ou Y; Sun SJ; Shi HM; Luo JF; Luo XP; Shen YZ; Chen YF; Fan WH; Liu HY; Shen W
Chin J Integr Med; 2020 Sep; 26(9):656-662. PubMed ID: 32572777
[TBL] [Abstract][Full Text] [Related]
9. Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experience.
Leonardi S; Lopes RD; Steg PG; Abnousi F; Menozzi A; Prats J; Mangum S; Wilson M; Todd M; Stone GW; Gibson CM; Hamm CW; Price MJ; White HD; Harrington RA; Bhatt DL; Mahaffey KW
Eur Heart J Acute Cardiovasc Care; 2018 Mar; 7(2):158-165. PubMed ID: 27485140
[TBL] [Abstract][Full Text] [Related]
10. Colchicine in Patients With Acute Coronary Syndrome: The Australian COPS Randomized Clinical Trial.
Tong DC; Quinn S; Nasis A; Hiew C; Roberts-Thomson P; Adams H; Sriamareswaran R; Htun NM; Wilson W; Stub D; van Gaal W; Howes L; Collins N; Yong A; Bhindi R; Whitbourn R; Lee A; Hengel C; Asrress K; Freeman M; Amerena J; Wilson A; Layland J
Circulation; 2020 Nov; 142(20):1890-1900. PubMed ID: 32862667
[TBL] [Abstract][Full Text] [Related]
11. Prima-vista multi-vessel percutaneous coronary intervention in haemodynamically stable patients with acute coronary syndromes: analysis of over 4.400 patients in the EHS-PCI registry.
Bauer T; Zeymer U; Hochadel M; Möllmann H; Weidinger F; Zahn R; Nef HM; Hamm CW; Marco J; Gitt AK
Int J Cardiol; 2013 Jul; 166(3):596-600. PubMed ID: 22192297
[TBL] [Abstract][Full Text] [Related]
12. Changes in serum serotonin levels in patients with acute coronary syndrome and stable angina undergoing percutaneous coronary intervention.
Han D; Choi JH; Kim S; Park SM; Shin DG; Kang MK; Choi S; Lee N; Cho JR
J Int Med Res; 2020 Dec; 48(12):300060520970104. PubMed ID: 33284714
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of High-Intensity Atorvastatin for Asian Patients Undergoing Percutaneous Coronary Intervention.
Liu Z; Joerg H; Hao H; Xu J; Hu S; Li B; Sang C; Xia J; Chu Y; Xu D
Ann Pharmacother; 2016 Sep; 50(9):725-33. PubMed ID: 27307415
[TBL] [Abstract][Full Text] [Related]
14. Combination of Mean Platelet Volume and Neutrophil to Lymphocyte Ratio Predicts Long-Term Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention.
Choi DH; Kobayashi Y; Nishi T; Kim HK; Ki YJ; Kim SS; Park KH; Song H; Fearon WF
Angiology; 2019 Apr; 70(4):345-351. PubMed ID: 29631419
[TBL] [Abstract][Full Text] [Related]
15. COlchicine to Prevent PeriprocEdural Myocardial Injury in Percutaneous Coronary Intervention (COPE-PCI): Coronary Microvascular Physiology Pilot Substudy.
Cole J; Htun N; Lew R; Freilich M; Quinn S; Layland J
J Interv Cardiol; 2022; 2022():1098429. PubMed ID: 35685430
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial.
Windecker S; Lopes RD; Massaro T; Jones-Burton C; Granger CB; Aronson R; Heizer G; Goodman SG; Darius H; Jones WS; Aschermann M; Brieger D; Cura F; Engstrøm T; Fridrich V; Halvorsen S; Huber K; Kang HJ; Leiva-Pons JL; Lewis BS; Malaga G; Meneveau N; Merkely B; Milicic D; Morais J; Potpara TS; Raev D; Sabaté M; de Waha-Thiele S; Welsh RC; Xavier D; Mehran R; Alexander JH;
Circulation; 2019 Dec; 140(23):1921-1932. PubMed ID: 31557056
[TBL] [Abstract][Full Text] [Related]
17. Clinical and prognostic value of poststenting fractional flow reserve in acute coronary syndromes.
Kasula S; Agarwal SK; Hacioglu Y; Pothineni NK; Bhatti S; Ahmed Z; Uretsky B; Hakeem A
Heart; 2016 Dec; 102(24):1988-1994. PubMed ID: 27492942
[TBL] [Abstract][Full Text] [Related]
18. Multivessel Versus Culprit Vessel-Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE-ACS Observational Study.
Ibrahim H; Sharma PK; Cohen DJ; Fonarow GC; Kaltenbach LA; Effron MB; Zettler ME; Peterson ED; Wang TY
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28982673
[TBL] [Abstract][Full Text] [Related]
19. Tissue characteristics of culprit lesion and myocardial tissue-level perfusion in non-ST-segment elevation acute coronary syndromes: The EARLY-MYO-ACS study.
Yang G; Wang W; Sheng X; Yang F; Kong L; He J; Ding S; Shan P; Shang Y; Xiu J; Yang Y; Mintz GS; Pu J
Int J Cardiol; 2019 Jul; 287():32-38. PubMed ID: 30772013
[TBL] [Abstract][Full Text] [Related]
20. Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial.
Lopes RD; de Barros E Silva PGM; de Andrade Jesuíno I; Santucci EV; Barbosa LM; Damiani LP; Nakagawa Santos RH; Laranjeira LN; Dall Orto FTC; Beraldo de Andrade P; de Castro Bienert IR; Alexander JH; Granger CB; Berwanger O
JAMA Cardiol; 2018 Nov; 3(11):1113-1118. PubMed ID: 30264159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
